Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

August 31, 2010

Conditions
Breast CancerEndometrial CancerKidney CancerLung CancerLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

metformin hydrochloride

DRUG

temsirolimus

Trial Locations (1)

N6A 4L6

London Regional Cancer Program at London Health Sciences Centre, London

Sponsors
All Listed Sponsors
lead

London Health Sciences Centre

OTHER

NCT00659568 - Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | Biotech Hunter | Biotech Hunter